Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Apr;79(4):306–312. doi: 10.1136/bjo.79.4.306

Treatment of non-resectable malignant iris tumours with custom designed plaque radiotherapy.

C L Shields 1, J A Shields 1, P De Potter 1, A D Singh 1, C Hernandez 1, L W Brady 1
PMCID: PMC505090  PMID: 7742272

Abstract

BACKGROUND--Plaque radiotherapy is the most common method of managing posterior uveal melanoma but its use for iris melanoma and iris metastases has not yet been evaluated. METHODS--Fourteen patients with non-resectable iris melanoma and four with iris metastasis were treated with plaque radiotherapy. The tumour response to treatment and the local side effects of the radioactive plaque were evaluated. RESULTS--In the iris melanoma group over a mean follow up of 26 (range 6-75) months, the tumour regressed in 13 of the 14 patients (93%) and recurred as diffuse seeding in one patient (7%). Despite large doses of radiation given transcorneally, the cornea developed epitheliopathy, abrasion, and oedema in only one case each. The major radiation side effects were localised iris vasculopathy without glaucoma in two cases, posterior synechiae in five cases, and cataract in six cases. In the iris metastasis group, tumour regression was observed in all four patients (100%) and radiation side effects were not evident over the relatively short mean follow up period of 8 (range 4-9) months. All of the 14 patients with irradiated iris melanoma have remained systemically healthy without metastasis while three of the four patients with irradiated iris metastases have died of metastases from the primary neoplasm. CONCLUSION--Custom designed plaque radiotherapy appears to be an effective alternative method of controlling non-resectable diffuse iris melanoma and solitary iris metastasis and has relatively few side effects.

Full text

PDF
306

Images in this article

308Image
on p.308
308Image
on p.308
308Image
on p.308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arentsen J. J., Green W. R. Melanoma of the iris: report of 72 cases treated surgically. Ophthalmic Surg. 1975 Summer;6(2):23–37. [PubMed] [Google Scholar]
  2. Ashton N., Wybar K. Primary tumours of the iris. Ophthalmologica. 1966;151(1):97–113. doi: 10.1159/000304885. [DOI] [PubMed] [Google Scholar]
  3. Augsburger J. J., Gamel J. W., Sardi V. F., Greenberg R. A., Shields J. A., Brady L. W. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol. 1986 May;104(5):655–661. doi: 10.1001/archopht.1986.01050170045019. [DOI] [PubMed] [Google Scholar]
  4. Brown G. C., Shields J. A., Sanborn G., Augsburger J. J., Savino P. J., Schatz N. J. Radiation retinopathy. Ophthalmology. 1982 Dec;89(12):1494–1501. doi: 10.1016/s0161-6420(82)34611-4. [DOI] [PubMed] [Google Scholar]
  5. CLEASBY G. W. Malignant melanoma of the iris. AMA Arch Ophthalmol. 1958 Sep;60(3):403–417. doi: 10.1001/archopht.1958.00940080421009. [DOI] [PubMed] [Google Scholar]
  6. Char D. H., Crawford J. B., Gonzales J., Miller T. Iris melanoma with increased intraocular pressure. Differentiation of focal solitary tumors from diffuse or multiple tumors. Arch Ophthalmol. 1989 Apr;107(4):548–551. doi: 10.1001/archopht.1989.01070010562032. [DOI] [PubMed] [Google Scholar]
  7. Grossniklaus H. E., Brown R. H., Stulting R. D., Blasberg R. D. Iris melanoma seeding through a trabeculectomy site. Arch Ophthalmol. 1990 Sep;108(9):1287–1290. doi: 10.1001/archopht.1990.01070110103033. [DOI] [PubMed] [Google Scholar]
  8. Gíslason I., Magnússon B., Tulinius H. Malignant melanoma of the uvea in Iceland 1955-1979. Acta Ophthalmol (Copenh) 1985 Aug;63(4):389–394. doi: 10.1111/j.1755-3768.1985.tb01550.x. [DOI] [PubMed] [Google Scholar]
  9. Jakobiec F. A., Silbert G. Are most iris "melanomas' really nevi? A clinicopathologic study of 189 lesions. Arch Ophthalmol. 1981 Dec;99(12):2117–2132. doi: 10.1001/archopht.1981.03930020993002. [DOI] [PubMed] [Google Scholar]
  10. Kersten R. C., Tse D. T., Anderson R. Iris melanoma. Nevus or malignancy? Surv Ophthalmol. 1985 May-Jun;29(6):423–433. doi: 10.1016/0039-6257(85)90207-3. [DOI] [PubMed] [Google Scholar]
  11. Makley T. A., Jr Management of melanomas of the anterior segment. Surv Ophthalmol. 1974 Nov-Dec;19(3):135–153. [PubMed] [Google Scholar]
  12. McGalliard J. N., Johnston P. B. A study of iris melanoma in Northern Ireland. Br J Ophthalmol. 1989 Aug;73(8):591–595. doi: 10.1136/bjo.73.8.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McLean I. W., Foster W. D., Zimmerman L. E. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 1982 Feb;13(2):123–132. doi: 10.1016/s0046-8177(82)80116-0. [DOI] [PubMed] [Google Scholar]
  14. Memmen J. E., McLean I. W. The long-term outcome of patients undergoing iridocyclectomy. Ophthalmology. 1990 Apr;97(4):429–432. doi: 10.1016/s0161-6420(90)32562-9. [DOI] [PubMed] [Google Scholar]
  15. Palm E., Linder B. Excision of tumours in the iris and the ciliary body. Acta Ophthalmol (Copenh) 1968;46(3):521–528. doi: 10.1111/j.1755-3768.1968.tb02840.x. [DOI] [PubMed] [Google Scholar]
  16. REESE A. B., CLEASBY G. W. The treatment of iris melanoma. Am J Ophthalmol. 1959 May;47(5 Pt 2):118–125. [PubMed] [Google Scholar]
  17. RONES B., ZIMMERMAN L. E. The prognosis of primary tumors of the iris treated by iridectomy. AMA Arch Ophthalmol. 1958 Aug;60(2):193–205. doi: 10.1001/archopht.1958.00940080207003. [DOI] [PubMed] [Google Scholar]
  18. Reese A. B., Jones I. S., Cooper W. C. Surgery for tumors of the iris and ciliary body. Am J Ophthalmol. 1968 Aug;66(2):173–184. doi: 10.1016/0002-9394(68)92062-x. [DOI] [PubMed] [Google Scholar]
  19. Shields C. L., Shields J. A., Shields M. B., Augsburger J. J. Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology. 1987 Jul;94(7):839–846. doi: 10.1016/s0161-6420(87)33537-7. [DOI] [PubMed] [Google Scholar]
  20. Shields J. A., Augsburger J. J., Brady L. W., Day J. L. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology. 1982 Oct;89(10):1201–1207. doi: 10.1016/s0161-6420(82)34658-8. [DOI] [PubMed] [Google Scholar]
  21. Shields J. A. Counseling the patient with a posterior uveal melanoma. Am J Ophthalmol. 1988 Jul 15;106(1):88–91. [PubMed] [Google Scholar]
  22. Shields J. A., Sanborn G. E., Augsburger J. J. The differential diagnosis of malignant melanoma of the iris. A clinical study of 200 patients. Ophthalmology. 1983 Jun;90(6):716–720. doi: 10.1016/s0161-6420(83)34500-0. [DOI] [PubMed] [Google Scholar]
  23. Shields J. A., Shields C. L., Donoso L. A. Management of posterior uveal melanoma. Surv Ophthalmol. 1991 Nov-Dec;36(3):161–195. doi: 10.1016/0039-6257(91)90001-v. [DOI] [PubMed] [Google Scholar]
  24. Shields J. A., Shields C. L., Ehya H., Eagle R. C., Jr, De Potter P. Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture. Ophthalmology. 1993 Nov;100(11):1677–1684. doi: 10.1016/s0161-6420(93)31418-1. [DOI] [PubMed] [Google Scholar]
  25. Shields J. A., Shields C. L. Hepatic metastases of diffuse iris melanoma 17 years after enucleation. Am J Ophthalmol. 1988 Dec 15;106(6):749–750. doi: 10.1016/0002-9394(88)90720-9. [DOI] [PubMed] [Google Scholar]
  26. Territo C., Shields C. L., Shields J. A., Augsburger J. J., Schroeder R. P. Natural course of melanocytic tumors of the iris. Ophthalmology. 1988 Sep;95(9):1251–1255. doi: 10.1016/s0161-6420(88)33022-8. [DOI] [PubMed] [Google Scholar]
  27. Wilson R. S., Fraunfelder F. T., Hanna C. Recurrent tapioca melanoma of the iris and ciliary body treated with the argon laser. Am J Ophthalmol. 1976 Aug;82(2):213–217. doi: 10.1016/0002-9394(76)90420-7. [DOI] [PubMed] [Google Scholar]
  28. Workman D. M., Weiner J. W. Melanocytic lesions of the iris--a clinocopathological study of 100 cases. Aust N Z J Ophthalmol. 1990 Nov;18(4):381–384. doi: 10.1111/j.1442-9071.1990.tb01821.x. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES